This year’s spoooooookiest pharma ads
It's a Lown Institute tradition to highlight pharma's fear-mongering on Halloween, and this year is no exception. More
Income volatility and heart health
Income volatility has a significant impact on financial security, which can affect heart health as well, according to new research. More
Prioritizing what patients care about
What a new study tells us about implementing shared decision making for older adults with multiple chronic conditions. More
The frequency and harms of care cascades
How often do care cascades happen, and what harms do they cause? More
Is medical education too focused on the “right answer”? Or not enough?
Some doctors say that medical school is focusing too much on social issues and not enough on curing patients. But others say the changes to medical education haven't gone far enough. More
Can value-based payments help reduce waste in health care?
Even though proven interventions exist to reduce waste on the clinical side, implementing them on a large scale is easier said than done... More
The RCT blind spot
Randomized controlled trials are known as the "gold standard" in medical research--but they also have a significant down-side... More
News story or advertisement? Advertorials obscure hospital sponsor
A new series of articles in the Boston Globe touts the generosity and quality of Boston Children’s hospital. But who is funding these articles…? More
Incidence vs mortality: Which cancers are we overdiagnosing?
Over the past several decades, the medical community has made many positive advances in cancer prevention and treatment, leading to reduced deaths from cancer. However, for some types of cancer, we have not improved mortality rates despite pouring billions of dollars into early detection efforts. Which types of cancers are we preventing, which types are […] More
Redefining informed consent: What do patients want to know?
A new study examines the definition of informed consent and finds that patients want to know much more than clinicians usually tell them. More
Routine urine testing: It’s a culture problem
Testing asymptomatic adults for urinary tract infections often leads to overdiagnosis and overtreatment. So why do doctors keep doing it? More
Testing a radical approach to cancer: Less chemotherapy
This oncologist is taking a "Lownian" approach to treating advanced cancer. More
Research on overuse harms: Where do we go from here?
How do we frame overuse not just as an issue of cost but also as an issue of harm? A recap of the Lown Institute meeting on overuse harms research. More
Why is it difficult to provide the right care to adults with dementia?
The latest edition in the Lown Right Care Series in American Family Physician offers tips for providing right care to adults with dementia. More
Virginia’s “best” hospital sues 6,000 patients each year
The University of Virginia Medical Center is ranked as the "best" hospital in Virginia by U.S. News & World Report, but the hospital is among the worst when it comes to suing patients for unpaid medical bills. More
The top ten overuse studies of 2018
Which studies on overuse in 2018 were the most influential? More
Overtreatment of diabetes leads to thousands of hospitalizations each year
A recent study finds that overtreatment of older adults for Type 2 diabetes is common, harmful, and preventable. More
What are private insurers doing to prevent fraud? Not Much.
Why aren't private insurers prosecuting people who commit fraud? Because it would hurt their bottom line, a ProPublica investigation finds. More
Press Release: For Grandparents Day, Recommend a Prescription Checkup
It's Grandparent's Day -- Do you know what medications your grandparents are taking? More
When a deal isn’t really a deal: Coupons for medical imaging
If you buy something you don't need at a high discount, does that make it a good deal? Why patients should be wary of Groupons for medical imaging. More